Judge Doyle made history in 2020 when she was elected JP for Pct.1, Place 1 becoming the first Black American woman to hold ...

IDRx’s lead candidate IDRX-42 is being investigated in a Phase I/IIb trial in patients with advanced gastrointestinal stromal ...

We'll look into spending and how a decision was made to replace the old barricades that… could withstand a U-Haul truck at 40 ...

Fintel reports that on January 17, 2025, JP Morgan downgraded their outlook for Lucky Strike Entertainment (NYSE:LUCK) from ...

We’ll hear from speakers representing Syneos Health, Flagship Pioneering, and IPSEN on pharma dealmakers’ 2025 intentions, ...

Asia Market Update: JP tech pares gains seen following TSMC Capex guidance; China achieves 2024 GDP target; Quieter day for ...

It’s been a busy week for Illumina at the JP Morgan 2025 Healthcare conference, with the company revealing partnerships and ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...

Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

A transformative $5 million gift from Jean-Pierre Conte to UCSF to established two endowed professorships in the Department ...